Agenus

Colon cancer cells magnified 400x under a microscope The cells are purple and take on spherical shapes around a round center
Biotech

Agenus scraps ph. 3 colorectal study to narrow focus to colon

Agenus has scrapped a phase 3 study of its combo therapy in colorectal cancer after just three months in order to go all-in on colon cancer.
James Waldron Jul 13, 2026 7:55am
long shot miss basketball hoop fail shoot

Agenus focuses on survival data as trial flops with no responses

Apr 20, 2026 5:53am
Deal terminate tear up end deal scrap

UroGen hands CTLA-4 drug back to Agenus after mulling ph. 1 data

Nov 6, 2025 10:00am
Charming view of the seaside resort town of Kas in Turkey Romantic lighthouse at the entrance to the port and a paraglider f

BMS oncology head swings to Syndax—Chutes & Ladders

May 16, 2025 8:30am
Deal terminate tear up end deal scrap

Incyte exits cancer pact, leaving Agenus weighing its options

Feb 11, 2025 7:55am
peeling an orange

Bristol Myers culls cell therapy deals with 2 biotechs

Dec 16, 2024 11:19am